Assessing Health Utilities in Schizophrenia

Voruganti, L. N. P.; Awad, A. George; Oyewumi, L. Kola; Cortese, Leonardo; Zirul, Sandra; Dhawan, Ravinder

doi:10.2165/00019053-200017030-00005

Cited by 36 publications

(33 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…116 These QoL values are therefore potentially useful for the economic evaluation and are reviewed and reported in Appendix 9. As Voruganti and colleagues 117 reported later results from the same study as Awad and colleagues 52 only the study by Voruganti and colleagues 117 is summarised in Appendix 9.…”

Section: Review Of Utility-based Qol Papers In Fepmentioning

confidence: 99%

“…Utility scores can only be derived from SF-36/12 scores when fully disaggregated scores are reported, so five of the nine papers are not useful as only aggregated SF-36/12 scores are provided. Four papers report utility values for patients with schizophrenia 117,[119][120][121] and two of these report values for a treated and untreated state. 120,121 Three of the four papers report patient-rated values whereas the other 117 used psychiatric nurses to rate preferences.…”

Section: Herrman and Colleagues 118mentioning

confidence: 99%

See 1 more Smart Citation

Structural neuroimaging in psychosis: a systematic review and economic evaluation

Albon¹,

Tsourapas²,

Frew³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts. These sugges...

show abstract

Section: Review Of Utility-based Qol Papers In Fepmentioning

confidence: 99%

Section: Herrman and Colleagues 118mentioning

confidence: 99%

Structural neuroimaging in psychosis: a systematic review and economic evaluation

Albon¹,

Tsourapas²,

Frew³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…(Thurstone and Chave, 1929) and utility revealed by preference (Drummond et al, 1997). Indeed, preferences are regularly used in the development of quality of life measurements: the EuroQol is an example (EuroQol Group, 1990), and a feasibility study of the paradigm of utility revealed by preference has been published in the field of schizophrenia (Voruganti et al, 2000).…”

Section: )mentioning

confidence: 99%

Outcome revealed by preference in schizophrenia (OPS): development of a new class of outcome measurements

Falissard

Bazin

Hardy-Baylé

2006

Int J Methods Psych Res

View full text Add to dashboard Cite

The objective of this paper is to describe the development of a new type of outcome measurement, based on revealed preference, which can be used in serious chronic illnesses. Fifteen texts of about 200 words each were written by one of the authors on the day-to-day life of 15 schizophrenic patients. These 15 'slices of life' thus described were then ranked in terms of acceptability by a second group of 10 schizophrenic patients and by a group of 12 relatives of schizophrenic patients. From these rankings, six situations were selected so as to obtain evenly distributed positioning on an axis of acceptability. These six situations comprised the final instrument. In administration, the patients were first asked if the 'slices of life' that were described were acceptable or not, then if the 'slices of life' described were more or less acceptable than their own lives. Two scores were derived, one for an absolute level and the other for a relative level of the patient's satisfaction with his or her existence. Validation results were presented to a new sample of 229 schizophrenic patients. Internal consistency appeared good and the initial ranking of the six situations in terms of acceptability was confirmed. This study encourages the development of global outcome measures based on revealed preference in chronic serious illnesses.

show abstract

“…Da questa ricerca sono emersi 29 articoli. (6,7,10, Gli strumenti utilizzati sono stati molteplici. 15 articoli hanno adottato i profili sanitari per la misura della qualità di vita.…”

Section: Selezione Della Letteraturaunclassified

La misura della qualità di vita e dell’utilità in farmacoeconomia: strumenti e loro applicazioni in una rassegna di letteratura

Chan¹

2002

View full text Add to dashboard Cite

SOMMARIOAbbiamo esaminato gli strumenti generici di misura della qualità di vita correlata alla salute utilizzati nelle valutazioni economiche. I differenti strumenti usati per misurare la qualità della vita e l'utilità sono stati suddivisi in categorie e brevemente introdotti. Sono state prese in rassegna le pubblicazioni relative alla qualità di vita comparse sulla rivista "PharmacoEconomics" nel periodo 1997-2001. Il nostro interesse era rivolto principalmente alle applicazioni del Profilo di salute SF-36 e della misura d'utilità EQ-5D. Sono stati inoltre ulteriormente analizzati alcuni articoli selezionati e discussi alcuni problemi metodologici relativi alla misura della qualità di vita e dell'utilità. QUALITÀ DI VITA E UTILITÀIn un ambito di scarsità, le decisioni riguardanti l'allocazione delle risorse sanitarie devono essere rese esplicite (1). Una valutazione economica è in grado di identificare e quantificare la relazione esistente tra l'input di risorse (i costi) e l'output (i benefici), dunque di valutare l'efficienza di un progetto (2). Tra i recenti approcci metodologici, l'analisi costo-utilità (CUA) è stata utilizzata con frequenza crescente nelle valutazioni economiche in ambito sanitario. La CUA misura i benefici in termini di utilità e utilizza un indicatore sintetico per valutarli. I rapporti di costo/efficacia misurati con la CUA sono pertanto sempre paragonabili tra loro.La misura dello stato di salute è una tappa cruciale nelle valutazioni economiche. La definizione di salute proposta mezzo secolo fa (1947) dall'OMS: "uno stato di benessere fisico, mentale e sociale completo, e non mera assenza di malattia", ha determinato una rivoluzione nelle valutazioni della salute. La qualità di vita correlata alla salute è il risultato concettuale di questo processo di revisione, radicato nella convinzione che le cure sanitarie non debbano solamente prolungare il corso della vita, ma anche migliorarne la qualità: "non aggiungete solo anni alla vita, ma anche vita agli anni" è lo slogan che riassume questo atteggiamento. Tale concetto considera lo stato di salute ABSTRACTIn a climate of economic scarcity, decisions about the allocation of healthcare resources need to be made explicit. An economic evaluation is able to identify and quantify the relationship between an input of resources and an output, hence to appreciate the efficiency of the project. One of the recent methodological approaches that has been used increasingly in health economic evaluations is the 'cost-utility analysis' (CUA). CUA considers benefits in utility terms and uses a unique index to assess them. We investigated the generic measurements of health related quality of life in the economic evaluation. Different instruments for evaluating quality of life and utility were categorized and briefly introduced. Literatures published in the journal "PharmacoEconomics" in 1997-2001 regarding quality of life and utility were reviewed. We were especially interested in the application of health profile SF-36 and utility measure EQ-5D. Select...

show abstract

Assessing Health Utilities in Schizophrenia

Cited by 36 publications

References 22 publications

Structural neuroimaging in psychosis: a systematic review and economic evaluation

Structural neuroimaging in psychosis: a systematic review and economic evaluation

Outcome revealed by preference in schizophrenia (OPS): development of a new class of outcome measurements

La misura della qualità di vita e dell’utilità in farmacoeconomia: strumenti e loro applicazioni in una rassegna di letteratura

Contact Info

Product

Resources

About